PRKAA2 and medulloblastoma: Recently, a study has shown that deleting both catalytic subunits (prkaa1 and prkaa2) from AMPK inactivated the enzyme and decreased the expression of multiple genes related to protein translation, including mTORC1 in an SHH medulloblastoma model [80].